PharmaCyte Biotech, Inc.: Form 8-K, filed Apr 13, 2022
Filed with the SEC on Apr 13, 2022 and accepted by EDGAR at Apr 13, 2022, 07:39 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001683168-22-002580. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.